Induction Lorlatinib in Stage III Non-small Cell Lung Cancer

NCT05740943 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Stage III NSCLC
Surgery

Interventions

DRUG: Lorlatinib

Sponsor

Guangdong Provincial People's Hospital

Collaborators

[object Object]
[object Object]
[object Object]